Patent · US Active

Formulations for nonsurgical exogenous crosslink therapy

US8283322B2 · kind B2 · utility

12Cited by
4References
40Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 1, 2009
Grant dateOct 9, 2012
Priority date
Expiry dateDec 12, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P19/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Improved methods and compositions for the treatment of native tissues with crosslinkers are provided. The methods and compositions will find particular use in increasing resistance to tearing, fissuring, rupturing, and/or delamination.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.